{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:59:17Z","timestamp":1758049157071,"version":"3.44.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bbrc.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T02:01:21Z","timestamp":1688522481000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function"],"prefix":"10.1016","volume":"675","author":[{"given":"Maria","family":"Ioannou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Fella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revekka","family":"Papacharalambous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1914-1340","authenticated-orcid":false,"given":"Demos","family":"Kynigopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5211-3427","authenticated-orcid":false,"given":"Elena","family":"Panayiotou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2023.07.001_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2023.07.001_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3233\/JAD-2010-1221","article-title":"Alzheimer's disease and the amyloid-beta peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J.\u00a0Alzheim. Dis. : JAD"},{"issue":"Suppl 1","key":"10.1016\/j.bbrc.2023.07.001_bib3","first-page":"S123","article-title":"Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration","volume":"33","author":"Wang","year":"2013","journal-title":"J.\u00a0Alzheim. Dis. : JAD"},{"key":"10.1016\/j.bbrc.2023.07.001_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947071","article-title":"Pharmacological activation of the C5a receptor leads to stimulation of the \u03b2-adrenergic receptor and alleviates cognitive impairment in a murine model of familial Alzheimer's disease","volume":"13","author":"Fella","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2023.07.001_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225417","article-title":"C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar A\u03b2 amyloid and preserves memory in a mouse model of familial Alzheimer's disease","volume":"14","author":"Panayiotou","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.07.001_bib6","doi-asserted-by":"crossref","first-page":"e1333","DOI":"10.1212\/WNL.0000000000010201","article-title":"Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment","volume":"95","author":"Switzer","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2023.07.001_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbrc.2023.07.001_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2023.07.001_bib9","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awn261","article-title":"Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain","volume":"131","author":"Boche","year":"2008","journal-title":"Brain : J. Neurol."},{"key":"10.1016\/j.bbrc.2023.07.001_bib10","doi-asserted-by":"crossref","first-page":"21562","DOI":"10.1074\/jbc.M100710200","article-title":"Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695","volume":"276","author":"Chishti","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2023.07.001_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.nbd.2006.03.012","article-title":"Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice","volume":"23","author":"Bellucci","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbrc.2023.07.001_bib12","first-page":"105","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","author":"Kraeuter","year":"2019","journal-title":"Methods in molecular biology (Clifton, N.J.), 1916"},{"key":"10.1016\/j.bbrc.2023.07.001_bib13","first-page":"847","article-title":"Murine models of Alzheimer's disease and their use in developing immunotherapies","author":"Wisniewski","year":"2010","journal-title":"Biochim Biophys Acta, 1802"},{"key":"10.1016\/j.bbrc.2023.07.001_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1089\/rej.2006.9.485","article-title":"VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment","volume":"9","year":"2006","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.bbrc.2023.07.001_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8020033","article-title":"New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection","volume":"8","author":"Haque","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbrc.2023.07.001_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood-brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2023.07.001_bib17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11011-016-9801-6","article-title":"Neuron specific enolase: a promising therapeutic target in acute spinal cord injury","volume":"31","author":"Haque","year":"2016","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbrc.2023.07.001_bib18","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1177\/1947601911423031","article-title":"Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies","volume":"2","author":"Shibuya","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbrc.2023.07.001_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2014.04.007","article-title":"Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease","volume":"570","author":"Schmidt","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2023.07.001_bib20","article-title":"Neuron-specific enolase level as a predictor of neurological outcome in near-hanging patients: a retrospective multicenter study","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2023.07.001_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.32607\/20758251-2015-7-2-42-47","article-title":"NeuN as a neuronal nuclear antigen and neuron differentiation marker","volume":"7","author":"Gusel'nikova","year":"2015","journal-title":"Acta Naturae"},{"key":"10.1016\/j.bbrc.2023.07.001_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/org.6.2.11687","article-title":"VEGF in the nervous system","volume":"6","author":"Rosenstein","year":"2010","journal-title":"Organogenesis"},{"key":"10.1016\/j.bbrc.2023.07.001_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020814","article-title":"Neuroprotective effect of vascular endothelial growth factor on motoneurons of the oculomotor system","volume":"22","author":"Silva-Hucha","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2023.07.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109121","article-title":"VEGF counteracts amyloid-\u03b2-induced synaptic dysfunction","volume":"35","author":"Martin","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbrc.2023.07.001_bib25","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1167\/iovs.10-5322","article-title":"Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells","volume":"51","author":"Skeie","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbrc.2023.07.001_bib26","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23008495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X23008495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:31:38Z","timestamp":1757766698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X23008495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"alternative-id":["S0006291X23008495"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.07.001","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of the CRND8 mouse model for cerebral amyloid angiopathy, exhibited increased levels of neuron specific enolase in brain tissue following long-term treatment with a modified C5a receptor agonist, accompanied by improved cognitive function","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}